Erythropoietin	B-protein
-dependent	O
induction	O
of	O
hemoglobin	B-protein
synthesis	O
in	O
a	O
cytokine-dependent	B-cell_line
cell	I-cell_line
line	I-cell_line
M-TAT	B-cell_line
.	O

M-TAT	B-cell_line
is	O
a	O
cytokine-dependent	B-cell_line
cell	I-cell_line
line	I-cell_line
with	O
the	O
potential	O
to	O
differentiate	O
along	O
the	O
erythroid	B-cell_type
and	I-cell_type
megakaryocytic	I-cell_type
lineages	I-cell_type
.	O

We	O
cultured	O
M-TAT	B-cell_line
cells	I-cell_line
long	O
term	O
(	O
>	O
1	O
year	O
)	O
in	O
the	O
continuous	O
presence	O
of	O
erythropoietin	B-protein
(	O
EPO	B-protein
)	O
,	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
,	O
or	O
stem	B-protein
cell	I-protein
factor	I-protein
(	O
SCF	B-protein
)	O
.	O

These	O
long	O
term	O
cultures	O
are	O
referred	O
to	O
as	O
M-TAT/EPO	B-cell_line
,	I-cell_line
M-TAT/GM-CSF	I-cell_line
,	I-cell_line
and	I-cell_line
M-TAT/SCF	I-cell_line
cells	I-cell_line
,	O
respectively	O
.	O

Hemoglobin	B-protein
concentration	O
and	O
gamma-globin	B-protein
and	O
erythroid	B-RNA
delta-aminolevulinate	I-RNA
synthase	I-RNA
mRNA	I-RNA
levels	O
were	O
significantly	O
higher	O
in	O
M-TAT/EPO	B-cell_line
cells	I-cell_line
than	O
in	O
M-TAT/GM-CSF	B-cell_line
cells	I-cell_line
.	O

When	O
the	O
supplemented	O
cytokine	B-protein
was	O
switched	O
from	O
GM-CSF	B-protein
to	O
EPO	B-protein
,	O
hemoglobin	B-protein
synthesis	O
in	O
M-TAT/GM-CSF	B-cell_line
cells	I-cell_line
increased	O
rapidly	O
(	O
within	O
5	O
h	O
)	O
,	O
and	O
the	O
level	O
of	O
GATA-1	B-RNA
mRNA	I-RNA
increased	O
.	O

In	O
contrast	O
,	O
the	O
addition	O
of	O
GM-CSF	B-protein
to	O
the	O
M-TAT/EPO	B-cell_line
cell	I-cell_line
culture	I-cell_line
decreased	O
the	O
amount	O
of	O
hemoglobin	O
,	O
even	O
in	O
the	O
presence	O
of	O
EPO	B-protein
,	O
indicating	O
that	O
the	O
EPO	B-protein
signal	O
for	O
erythroid	O
differentiation	O
is	O
suppressed	O
by	O
GM-CSF	B-protein
.	O

Thus	O
,	O
erythroid	O
development	O
of	O
M-TAT	B-cell_line
cells	I-cell_line
is	O
promoted	O
by	O
EPO	B-protein
and	O
suppressed	O
by	O
GM-CSF	B-protein
.	O

These	O
results	O
support	O
the	O
hypothesis	O
that	O
EPO	B-protein
actively	O
influences	O
the	O
programming	O
of	O
gene	O
expression	O
required	O
for	O
erythroid	B-cell_type
progenitor	I-cell_type
cell	I-cell_type
differentiation	O
.	O

Tir	NULL
Journat	NULL
or	NULL
Brorocican	NULL
Casmisrny	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

44	NULL
,	NULL
Issue	NULL
of	NULL
November	NULL
4	NULL
,	NULL
pp	NULL
.	NULL

27700-27704	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Erythropoietin-dependent	NULL
Induction	NULL
of	NULL
Hemoglobin	NULL
Synthesis	NULL
in	NULL
a	NULL
Cytokine-dependent	NULL
Cell	NULL
Line	NULL
M-TAT*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
June	NULL
22	NULL
,	NULL
1994	NULL
)	NULL
Naoko	NULL
Minegishi	NULL
,	NULL
Masayoshi	NULL
Minegishi	NULL
,	NULL
Shigeru	NULL
Tsuchiya	NULL
,	NULL
Hiromi	NULL
Fujie	NULL
,	NULL
Tadashi	NULL
Nagai	NULL
,	NULL
Norio	NULL
Hayashit	NULL
,	NULL
Masayuki	NULL
Yamamoto	NULL
#	NULL
§	NULL
,	NULL
and	NULL
Tasuke	NULL
Konno	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Pediatric	NULL
Oncology	NULL
,	NULL
Institute	NULL
of	NULL
Development	NULL
,	NULL
Aging	NULL
,	NULL
and	NULL
Cancer	NULL
,	NULL
Tohoku	NULL
University	NULL
and	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Sendai	NULL
980	NULL
,	NULL
Japan	NULL
M-TAT	NULL
is	NULL
a	NULL
cytokine-dependent	NULL
cell	NULL
line	NULL
with	NULL
the	NULL
potential	NULL
to	NULL
differentiate	NULL
along	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
.	NULL

We	NULL
cultured	NULL
M-TAT	NULL
cells	NULL
long	NULL
term	NULL
(	NULL
>	NULL
1	NULL
year	NULL
)	NULL
in	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
or	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
.	NULL

These	NULL
long	NULL
term	NULL
cultures	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
M-TAT/EPO	NULL
,	NULL
M-TAT/GM-CSF	NULL
,	NULL
and	NULL
M-TAT/SCF	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Hemoglobin	NULL
concentration	NULL
and	NULL
y-globin	NULL
and	NULL
erythroid	NULL
#	NULL
-aminolevu-linate	NULL
synthase	NULL
mRNA	NULL
levels	NULL
were	NULL
significantly	NULL
higher	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
than	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
supplemented	NULL
cytokine	NULL
was	NULL
switched	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
,	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
increased	NULL
rapidly	NULL
(	NULL
within	NULL
5	NULL
h	NULL
)	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
increased	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
to	NULL
the	NULL
M-TAT/EPO	NULL
cell	NULL
culture	NULL
decreased	NULL
the	NULL
amount	NULL
of	NULL
he-moglobin	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EPO	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
EPO	NULL
signal	NULL
for	NULL
erythroid	NULL
differentiation	NULL
is	NULL
suppressed	NULL
by	NULL
GM-CSF	NULL
.	NULL

Thus	NULL
,	NULL
erythroid	NULL
development	NULL
of	NULL
M-TAT	NULL
cells	NULL
is	NULL
promoted	NULL
by	NULL
EPO	NULL
and	NULL
suppressed	NULL
by	NULL
GM-CSF	NULL
.	NULL

These	NULL
results	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
EPO	NULL
actively	NULL
influences	NULL
the	NULL
programming	NULL
of	NULL
gene	NULL
expression	NULL
required	NULL
for	NULL
erythroid	NULL
progenitor	NULL
cell	NULL
differentiation	NULL
.	NULL

Since	NULL
the	NULL
discovery	NULL
of	NULL
cytokines	NULL
,	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
research	NULL
has	NULL
concentrated	NULL
on	NULL
the	NULL
elucidation	NULL
of	NULL
cytokine	NULL
func-tions	NULL
.	NULL

A	NULL
number	NULL
of	NULL
cytokines	NULL
are	NULL
able	NULL
to	NULL
support	NULL
the	NULL
growth	NULL
of	NULL
hematopoietic	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
possibility	NULL
of	NULL
a	NULL
common	NULL
signaling	NULL
pathway	NULL
has	NULL
been	NULL
vigorously	NULL
investigated	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
fundamental	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
cytokines	NULL
merely	NULL
serve	NULL
to	NULL
salvage	NULL
preprogrammed	NULL
cells	NULL
from	NULL
apoptosis	NULL
or	NULL
actively	NULL
influence	NULL
the	NULL
programming	NULL
of	NULL
gene	NULL
expression	NULL
required	NULL
for	NULL
cellular	NULL
differentiation	NULL
remains	NULL
to	NULL
be	NULL
clarified	NULL
(	NULL
4-7	NULL
)	NULL
.	NULL

Erythropoietin	NULL
(	NULL
EPO	NULL
)	NULL
!	NULL

is	NULL
a	NULL
cytokine	NULL
that	NULL
supports	NULL
proliferation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
.	NULL

EPO	NULL
functions	NULL
by	NULL
binding	NULL
to	NULL
a	NULL
specific	NULL
cell	NULL
surface	NULL
receptor	NULL
(	NULL
9	NULL
)	NULL
(	NULL
erythropoietin	NULL
receptor	NULL
,	NULL
EPO-R	NULL
)	NULL
and	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
promote	NULL
the	NULL
differentiation	NULL
of	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
several	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
origin	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants-in-aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
and	NULL
the	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
Welfare	NULL
,	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Gonryo	NULL
Foundation	NULL
for	NULL
the	NULL
Promotion	NULL
of	NULL
Medical	NULL
Sciences	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Biochemistry	NULL
,	NULL
Tohoku	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
2-1	NULL
Seiryomachi	NULL
,	NULL
Aoba-ku	NULL
,	NULL
Sendai	NULL
980	NULL
,	NULL
Japan	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
§1-22-273-9065	NULL
;	NULL
Fax	NULL
:	NULL
81-22-274-5698	NULL
.	NULL
'	NULL

The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
EPO	NULL
,	NULL
erythropoietin	NULL
;	NULL
dianisidine	NULL
,	NULL
3,8'-dimethoxybenzidine	NULL
,	NULL
fast	NULL
blue	NULL
B	NULL
;	NULL
EPO-R	NULL
,	NULL
EPO	NULL
receptor	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte	NULL
macrophage-colony	NULL
stimulation	NULL
factor	NULL
;	NULL
SCF	NULL
,	NULL
stem	NULL
cell	NULL
factor	NULL
.	NULL

have	NULL
already	NULL
been	NULL
established	NULL
and	NULL
used	NULL
as	NULL
models	NULL
for	NULL
the	NULL
characterization	NULL
of	NULL
EPO	NULL
function	NULL
in	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
(	NULL
7	NULL
,	NULL
13-17	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
cytokines	NULL
on	NULL
the	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
,	NULL
we	NULL
established	NULL
a	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
-dependent	NULL
cell	NULL
line	NULL
,	NULL
M-TAT	NULL
.	NULL

*	NULL
As	NULL
M-TAT	NULL
cells	NULL
also	NULL
grow	NULL
in	NULL
media	NULL
containing	NULL
either	NULL
EPO	NULL
or	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
SCF	NULL
)	NULL
,	NULL
we	NULL
cultured	NULL
M-TAT	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
or	NULL
SCF	NULL
for	NULL
1	NULL
year	NULL
.	NULL

These	NULL
long	NULL
term	NULL
cultured	NULL
lines	NULL
of	NULL
M-TAT	NULL
cells	NULL
are	NULL
tentatively	NULL
named	NULL
as	NULL
M-TAT/GM-CSF	NULL
,	NULL
M-TAT/EPO	NULL
,	NULL
and	NULL
M-TAT/SCF	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
found	NULL
that	NULL
,	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
other	NULL
two	NULL
M-TAT	NULL
lines	NULL
,	NULL
M-TAT/EPO	NULL
cells	NULL
show	NULL
the	NULL
highest	NULL
level	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
.	NULL

Using	NULL
these	NULL
M-TAT	NULL
cell	NULL
cultures	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
cytokine-switching	NULL
experiments	NULL
.	NULL

Switching	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
induced	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
within	NULL
48	NULL
h	NULL
without	NULL
any	NULL
impairment	NULL
of	NULL
cell	NULL
growth	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
switching	NULL
from	NULL
EPO	NULL
to	NULL
GM-CSF	NULL
,	NULL
or	NULL
adding	NULL
GM-CSF	NULL
to	NULL
the	NULL
M-TAT/EPO	NULL
cell	NULL
culture	NULL
,	NULL
markedly	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
hemoglobin	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
EPO	NULL
signal	NULL
for	NULL
erythroid	NULL
differentiation	NULL
is	NULL
suppressed	NULL
and/or	NULL
overridden	NULL
by	NULL
the	NULL
GM-CSF	NULL
signal	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
EPO/EPO-R	NULL
system	NULL
plays	NULL
a	NULL
specific	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture-M-TAT	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
suspension	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Cell	NULL
Culture	NULL
Laboratories	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
incuba-tor	NULL
.	NULL

The	NULL
original	NULL
M-TAT	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
divided	NULL
into	NULL
three	NULL
culture	NULL
flasks	NULL
and	NULL
placed	NULL
in	NULL
medium	NULL
containing	NULL
one	NULL
of	NULL
following	NULL
cytokines	NULL
:	NULL
recombinant	NULL
human	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
,	NULL
Hoechst	NULL
Japan	NULL
,	NULL
Tokyo	NULL
)	NULL
;	NULL
recombinant	NULL
human	NULL
EPO	NULL
(	NULL
50	NULL
ng/ml	NULL
(	NULL
10	NULL
units/ml	NULL
)	NULL
,	NULL
Kirin	NULL
Beer	NULL
,	NULL
Tokyo	NULL
)	NULL
or	NULL
recombinant	NULL
SCF	NULL
(	NULL
100	NULL
ng/ml	NULL
,	NULL
Genzyme	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL
)	NULL

.	NULL

After	NULL
12	NULL
months	NULL
of	NULL
culturing	NULL
the	NULL
M-TAT	NULL
cells	NULL
in	NULL
their	NULL
respective	NULL
cytokine	NULL
,	NULL
frozen	NULL
cell	NULL
stocks	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
optimal	NULL
concentration	NULL
of	NULL
each	NULL
cytokine	NULL
was	NULL
determined	NULL
empirically	NULL
by	NULL
thymidine	NULL
uptake	NULL
assays	NULL
(	NULL
1-10	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
and	NULL
10	NULL
ng/ml	NULL
of	NULL
EPO®	NULL
)	NULL
.	NULL

The	NULL
original	NULL
M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
GM-CSF	NULL
as	NULL
the	NULL
original	NULL
M-TAT	NULL
cells	NULL
,	NULL
so	NULL
both	NULL
lines	NULL
are	NULL
essentially	NULL
the	NULL
same	NULL
.	NULL

Dianisidine	NULL
Staining-Hemoglobin	NULL
concentration	NULL
was	NULL
examined	NULL
by	NULL
incubating	NULL
cells	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
0.2	NULL
%	NULL
3,8'-dimethoxybenzidine	NULL
,	NULL
fast	NULL
blue	NULL
B	NULL
(	NULL
dianisidine	NULL
,	NULL
Sigma	NULL
)	NULL
,	NULL
0.3	NULL
%	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
0.3	NULL
%	NULL
H,0	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Subcloning	NULL
of	NULL
M-TAT/GM-CSF	NULL
and	NULL
M-TAT/EPO	NULL
Cells-¥Fifty	NULL
M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
.	NULL

Twenty-one	NULL
days	NULL
later	NULL
,	NULL
15	NULL
wells	NULL
contained	NULL
proliferating	NULL
cells	NULL
and	NULL
were	NULL
expanded	NULL
.	NULL

Six	NULL
out	NULL
of	NULL
the	NULL
15	NULL
expanded	NULL
subclones	NULL
subsequently	NULL
died	NULL
.	NULL

Two	NULL
subclones	NULL
were	NULL
obtained	NULL
(	NULL
M-TAT/E-9	NULL
and	NULL
M-TAT/H-9	NULL
)	NULL
and	NULL
re-sub-cloned	NULL
similarly	NULL
by	NULL
seeding	NULL
10	NULL
cells/96-well	NULL
plate	NULL
.	NULL

Fifty	NULL
M-TAT/EPO	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
,	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
ng/ml	NULL
of	NULL
EPO	NULL
for	NULL
3	NULL
weeks	NULL
.	NULL

Eight	NULL
wells	NULL
*	NULL
N.	NULL
Minegishi	NULL
,	NULL
M.	NULL
Minegishi	NULL
,	NULL
S.	NULL
Tsuchiya	NULL
,	NULL
and	NULL
T.	NULL
Konno	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

27700	NULL
Erythropoietin-dependent	NULL
Differentiation	NULL
in	NULL
M-TAT	NULL
Cells	NULL
Number	NULL
of	NULL
Cells	NULL
(	NULL
x	NULL
10°	NULL
/m	NULL
!	NULL
)	NULL

day	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Growth	NULL
profiles	NULL
of	NULL
M-TAT	NULL
cells	NULL
.	NULL

M-TAT/GM-CSF	NULL
(	NULL
@	NULL
)	NULL
and	NULL
M-TAT/EPO	NULL
cells	NULL
(	NULL
O	NULL
)	NULL
(	NULL
1	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
each	NULL
cytokine	NULL
.	NULL

M-TAT/EPO	NULL
cells	NULL
(	NULL
x	NULL
)	NULL
and	NULL
M-TAT/GM-CSF	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
cytokines	NULL
.	NULL

Means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

contained	NULL
proliferating	NULL
cells	NULL
,	NULL
and	NULL
4	NULL
subclones	NULL
were	NULL
obtained	NULL
after	NULL
expansion	NULL
of	NULL
these	NULL
.	NULL

RNA	NULL
Preparation	NULL
and	NULL
Blot	NULL
Hybridization	NULL
Analysis-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
cells	NULL
in	NULL
logarithmic	NULL
growth	NULL
phase	NULL
utilizing	NULL
the	NULL
guanidinium	NULL
isothiocyanate	NULL
procedure	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
run	NULL
on	NULL
a	NULL
1.0	NULL
%	NULL
agarose/formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
(	NULL
Hybond	NULL
C-extra	NULL
,	NULL
Amersham	NULL
Corp.	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
the	NULL
following	NULL
probes	NULL
:	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
(	NULL
K101	NULL
,	NULL
Ref	NULL
.	NULL

20	NULL
)	NULL
,	NULL
human	NULL
GATA-2	NULL
cDNA	NULL
(	NULL
nucleotides	NULL
1000-1400	NULL
,	NULL
Ref	NULL
.	NULL

21	NULL
)	NULL
,	NULL
human	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
cDNA	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
y-globin	NULL
cDNA	NULL
(	NULL
JW151	NULL
;	NULL
provided	NULL
by	NULL
the	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resource	NULL
Bank	NULL
)	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
*P	NULL
]	NULL
dCTP	NULL
by	NULL
the	NULL
random-priming	NULL
method	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
exposed	NULL
to	NULL
a	NULL
phosphor-imaging	NULL
plate	NULL
and	NULL
analyzed	NULL
by	NULL
a	NULL
BAS	NULL
2000	NULL
image	NULL
analyzer	NULL
(	NULL
Fuji	NULL
Film	NULL
,	NULL
Tokyo	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
extracted	NULL
from	NULL
other	NULL
cell	NULL
lines	NULL
was	NULL
used	NULL
as	NULL
positive	NULL
(	NULL
YN-1	NULL
(	NULL
25	NULL
)	NULL
,	NULL
HEL	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
K-562	NULL
(	NULL
27	NULL
)	NULL
)	NULL
and	NULL
negative	NULL
(	NULL
M-MOK	NULL
(	NULL
28	NULL
)	NULL
)	NULL
controls	NULL
of	NULL
the	NULL
analysis	NULL
.	NULL

M-MOK	NULL
cells	NULL
were	NULL
established	NULL
from	NULL
blasts	NULL
of	NULL
acute	NULL
myeloblastic	NULL
leukemia	NULL
patients	NULL
and	NULL
do	NULL
not	NULL
express	NULL
erythroid	NULL
markers	NULL
.	NULL

:	NULL
YN-1	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
HEL	NULL
are	NULL
chronic	NULL
myelogenous	NULL
leukemia-derived	NULL
cell	NULL
lines	NULL
that	NULL
express	NULL
an	NULL
erythroid	NULL
phenotype	NULL
.	NULL

RESULTS	NULL
M-TAT	NULL
Cells	NULL
Are	NULL
Dependent	NULL
on	NULL
Cytokines	NULL
for	NULL
Viability	NULL
and	NULL
M-TAT/EPO	NULL
Cells	NULL
Express	NULL
Erythroid-specific	NULL
Genes	NULL
at	NULL
High	NULL
Levels-M-TAT	NULL
is	NULL
a	NULL
new	NULL
GM-CSF-dependent	NULL
cell	NULL
line	NULL
established	NULL
from	NULL
peripheral	NULL
blood	NULL
cells	NULL
of	NULL
a	NULL
leukemia	NULL
patient	NULL
.	NULL
``	NULL

M-TAT	NULL
cells	NULL
are	NULL
also	NULL
capable	NULL
of	NULL
proliferating	NULL
with	NULL
EPO	NULL
,	NULL
interleu-kin-3	NULL
,	NULL
or	NULL
SCF	NULL
,	NULL
so	NULL
we	NULL
cultured	NULL
M-TAT	NULL
cells	NULL
long	NULL
term	NULL
(	NULL
>	NULL
12	NULL
months	NULL
)	NULL
in	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
or	NULL
SCF	NULL
.	NULL

These	NULL
long	NULL
term	NULL
cell	NULL
cultures	NULL
were	NULL
tentatively	NULL
named	NULL
as	NULL
M-TAT/GM-CSF	NULL
,	NULL
M-TAT/EPO	NULL
,	NULL
and	NULL
M-TAT/SCF	NULL
,	NULL
respectively	NULL
.	NULL

All	NULL
three	NULL
cell	NULL
lines	NULL
are	NULL
dependent	NULL
on	NULL
cytokines	NULL
for	NULL
viability	NULL
as	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
each	NULL
cytokine	NULL
,	NULL
cells	NULL
proliferate	NULL
normally	NULL
,	NULL
but	NULL
they	NULL
stop	NULL
proliferating	NULL
and	NULL
eventually	NULL
die	NULL
when	NULL
the	NULL
cytokines	NULL
are	NULL
omitted	NULL
from	NULL
the	NULL
culture	NULL
medium	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
had	NULL
established	NULL
and	NULL
maintained	NULL
the	NULL
original	NULL
M-TAT	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
,	NULL
so	NULL
the	NULL
properties	NULL
of	NULL
M-TAT/GM-CSF	NULL
cells	NULL
are	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
the	NULL
original	NULL
M-TAT	NULL
cells	NULL
.	NULL

Original	NULL
M-TAT	NULL
cells	NULL
stained	NULL
positively	NULL
with	NULL
anti-glycoph-orin	NULL
A	NULL
antibody	NULL
,	NULL
``	NULL
indicating	NULL
that	NULL
they	NULL
are	NULL
committed	NULL
to	NULL
the	NULL
erythroid	NULL
lineage	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
three	NULL
M-TAT	NULL
long	NULL
term	NULL
cultures	NULL
had	NULL
maintained	NULL
their	NULL
erythroid	NULL
properties	NULL
or	NULL
changed	NULL
them	NULL
,	NULL
we	NULL
stained	NULL
the	NULL
cells	NULL
for	NULL
hemoglobin	NULL
with	NULL
dia-	NULL
°	NULL
M.	NULL
Itano	NULL
,	NULL
S.	NULL
Tsuchiya	NULL
,	NULL
N.	NULL
Minegishi	NULL
,	NULL
H.	NULL
Fujie	NULL
,	NULL
M.	NULL
Minegishi	NULL
,	NULL
S.	NULL
Morita	NULL
,	NULL
T.	NULL
Yambe	NULL
,	NULL
Y.	NULL
Ohashi	NULL
,	NULL
T.	NULL
Masuda	NULL
,	NULL
and	NULL
T.	NULL
Konno	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

27701	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Blot	NULL
hybridization	NULL
analysis	NULL
of	NULL
erythroid-specific	NULL
5-ami-nolevulinate	NULL
synthase	NULL
and	NULL
y-globin	NULL
mRNAs	NULL
in	NULL
M-TAT	NULL
cells	NULL
.	NULL

RNA	NULL
isolated	NULL
from	NULL
cell	NULL
lines	NULL
was	NULL
probed	NULL
with	NULL
random	NULL
primer-labeled	NULL
erythroid-specific	NULL
d-aminolevulinate	NULL
synthase	NULL
(	NULL
ALAS-E	NULL
)	NULL
,	NULL
y-globin	NULL
,	NULL
or	NULL
rRNA	NULL
probes	NULL
.	NULL

Cell	NULL
lines	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
M-MOK	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
M-TAT/EPO	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
M-TAT/SCF	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
M-TAT/GM-CSF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
HEL	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
YN-1	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
K562	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

nisidine	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
frequency	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
was	NULL
unexpectedly	NULL
high	NULL
(	NULL
30-50	NULL
%	NULL
)	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
,	NULL
whereas	NULL
those	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
was	NULL
less	NULL
than	NULL
10	NULL
%	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
long	NULL
term	NULL
culture	NULL
of	NULL
M-TAT	NULL
cells	NULL
with	NULL
EPO	NULL
promotes	NULL
the	NULL
maintenance	NULL
of	NULL
an	NULL
eryth-roid-differentiated	NULL
state	NULL
of	NULL
the	NULL
M-TAT	NULL
cells	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
mRNAs	NULL
encoding	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
,	NULL
the	NULL
first	NULL
regulatory	NULL
enzyme	NULL
of	NULL
the	NULL
erythroid	NULL
heme	NULL
biosynthetic	NULL
pathway	NULL
,	NULL
and	NULL
y-globin	NULL
by	NULL
RNA	NULL
blot	NULL
analysis	NULL
.	NULL

Erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
and	NULL
y-globin	NULL
mRNAs	NULL
were	NULL
detected	NULL
in	NULL
all	NULL
M-TAT	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
M-TAT	NULL
cells	NULL
are	NULL
committed	NULL
to	NULL
the	NULL
erythroid	NULL
lineage	NULL
.	NULL

The	NULL
important	NULL
observation	NULL
in	NULL
this	NULL
analysis	NULL
is	NULL
that	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
dianisidine	NULL
staining	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
and	NULL
y-globin	NULL
mRNAs	NULL
were	NULL
much	NULL
higher	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
than	NULL
in	NULL
M-TAT/GM-CSF	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
cells	NULL
.	NULL

Levels	NULL
of	NULL
erythroid-specific	NULL
d-aminolevulinate	NULL
synthase	NULL
mRNA	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
are	NULL
comparable	NULL
with	NULL
levels	NULL
found	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
mRNA	NULL
,	NULL
the	NULL
highest	NULL
among	NULL
tested	NULL
human	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

*	NULL
EPO	NULL
Stimulates	NULL
the	NULL
Expression	NULL
of	NULL
Erythroid	NULL
Genes	NULL
in	NULL
M-TAT/GM-CSF	NULL
Cells-We	NULL
hypothesized	NULL
that	NULL
,	NULL
if	NULL
EPO	NULL
actively	NULL
induces	NULL
the	NULL
erythroid	NULL
differentiation	NULL
program	NULL
,	NULL
it	NULL
may	NULL
induce	NULL
erythroid	NULL
differentiation	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
in	NULL
much	NULL
less	NULL
than	NULL
12	NULL
months	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
EPO	NULL
can	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
late	NULL
erythroid	NULL
genes	NULL
in	NULL
M-TAT	NULL
cells	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
a	NULL
series	NULL
of	NULL
cytokine-switching	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
supplemented	NULL
cytokine	NULL
was	NULL
switched	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
and	NULL
vice	NULL
versa	NULL
.	NULL

M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
replated	NULL
with	NULL
media	NULL
supplemented	NULL
with	NULL
EPO	NULL
.	NULL

This	NULL
switch	NULL
of	NULL
cytokines	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
increase	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

The	NULL
percent	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
increased	NULL
from	NULL
6	NULL
to	NULL
30	NULL
%	NULL
within	NULL
72	NULL
h	NULL
after	NULL
switching	NULL
to	NULL
EPO	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
mRNAs	NULL
in	NULL
M-TAT/	NULL
GM-CSF	NULL
cells	NULL
also	NULL
increased	NULL
significantly	NULL
within	NULL
48	NULL
h	NULL
of	NULL
the	NULL
switch	NULL
to	NULL
EPO	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
switching	NULL
from	NULL
EPO	NULL
to	NULL
GM-CSF	NULL
,	NULL
which	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
M-TAT/EPO	NULL
cells	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
of	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
mRNAs	NULL
within	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
decreased	NULL
from	NULL
44	NULL
to	NULL
8	NULL
%	NULL
within	NULL
48	NULL
h	NULL
after	NULL
the	NULL
switch	NULL
to	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

The	NULL
growth	NULL
of	NULL
M-TAT	NULL
cells	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
these	NULL
cytokine	NULL
switches	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
,	NULL
and	NULL
no	NULL
apparent	NULL
morphological	NULL
changes	NULL
*T.	NULL
Nagai	NULL
and	NULL
M.	NULL
Yamamoto	NULL
,	NULL
unpublished	NULL
observation	NULL
.	NULL

27702	NULL
J	NULL
>	NULL
UJ	NULL
30	NULL
40	NULL
|	NULL
E	NULL
2	NULL
3	NULL
€	NULL
8	NULL
so	NULL
P	NULL
I	NULL
?	NULL

B	NULL
E	NULL
``	NULL
20	NULL
3	NULL
8	NULL
``	NULL
~I	NULL
1	NULL
-C	NULL
&	NULL
o	NULL
0	NULL
.2	NULL
[	NULL
=	NULL
sat	NULL
£	NULL
40	NULL
|	NULL
_	NULL
%	NULL
2	NULL
@	NULL
yo	NULL
&	NULL
CC	NULL
&	NULL
©	NULL
0	NULL
i	NULL
i	NULL
i	NULL
©	NULL
p	NULL
2o	NULL
40	NULL
60	NULL
80	NULL
C	NULL
Hour	NULL
m	NULL
13	NULL
£	NULL
2	NULL
ip	NULL
|	NULL
.	NULL

>	NULL
o	NULL
0	NULL
ve	NULL
6	NULL
A	NULL
.J	NULL
h	NULL
G	NULL
==	NULL
&	NULL
®	NULL
&	NULL
C	NULL
O	NULL
s	NULL
©	NULL
4s	NULL
Iz	NULL
3	NULL
B	NULL
_	NULL
£C	NULL
€	NULL
3	NULL
#	NULL
0	NULL
i	NULL
i	NULL
il	NULL
0	NULL
20	NULL
40	NULL
60	NULL
-	NULL
80	NULL
0	NULL
20	NULL
40	NULL
_	NULL
60	NULL
80	NULL
Hour	NULL
Hour	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Cytokine-switching	NULL
experiment	NULL
with	NULL
M-TAT	NULL
cells	NULL
.	NULL

M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
placed	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
EPO	NULL
(	NULL
@	NULL
)	NULL
.	NULL

M-TAT/EPO	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
placed	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
but	NULL
with	NULL
GM-CSF	NULL
(	NULL
O	NULL
)	NULL
.	NULL

A	NULL
,	NULL
changes	NULL
in	NULL
hemoglobin	NULL
production	NULL
after	NULL
cytokine-switching	NULL
was	NULL
determined	NULL
by	NULL
dianisidine	NULL
staining	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
cells	NULL
at	NULL
various	NULL
time	NULL
points	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
y-globin	NULL
(	NULL
B	NULL
)	NULL
and	NULL
erythroid-specific	NULL
d-aminolevulinate	NULL
synthase	NULL
(	NULL
C	NULL
)	NULL
mRNAs	NULL
were	NULL
determined	NULL
.	NULL

Relative	NULL
changes	NULL
of	NULL
radioactivity	NULL
were	NULL
determined	NULL
using	NULL
28	NULL
S	NULL
ribosomal	NULL
RNA	NULL
as	NULL
standard	NULL
.	NULL

D	NULL
,	NULL
viable	NULL
cell	NULL
count	NULL
in	NULL
the	NULL
culture	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
of	NULL
each	NULL
switching	NULL
showed	NULL
similar	NULL
results	NULL
.	NULL

were	NULL
observed	NULL
during	NULL
the	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
signals	NULL
mediated	NULL
by	NULL
the	NULL
EPO/EPO-R	NULL
system	NULL
actively	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
.	NULL

Cytokine-switching	NULL
Experiments	NULL
with	NULL
Monoclonal	NULL
Populations	NULL
of	NULL
M-TAT/GM-CSF	NULL
and	NULL
M-TAT	NULL
/	NULL
EPO	NULL
Cells-We	NULL
assumed	NULL
that	NULL
the	NULL
original	NULL
M-TAT	NULL
cells	NULL
and	NULL
each	NULL
serially	NULL
transferred	NULL
M-TAT	NULL
cell	NULL
culture	NULL
achieved	NULL
homogeneity	NULL
during	NULL
continuous	NULL
passage	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
if	NULL
the	NULL
M-TAT/GM-CSF	NULL
and	NULL
M-TAT/EPO	NULL
cells	NULL
were	NULL
not	NULL
monoclonal	NULL
,	NULL
that	NULL
is	NULL
,	NULL
some	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
were	NULL
responsive	NULL
to	NULL
EPO	NULL
and	NULL
others	NULL
were	NULL
responsive	NULL
to	NULL
GM-CSF	NULL
,	NULL
this	NULL
heterogeneity	NULL
could	NULL
underlie	NULL
the	NULL
observed	NULL
EPO-mediated	NULL
erythroid	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
eliminate	NULL
this	NULL
possibil-ity	NULL
,	NULL
we	NULL
generated	NULL
subclones	NULL
of	NULL
the	NULL
M-TAT/GM-CSF	NULL
and	NULL
M-TAT/	NULL
EPO	NULL
cell	NULL
lines	NULL
by	NULL
the	NULL
limiting	NULL
dilution	NULL
method	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
50	NULL
M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
.	NULL

Fifteen	NULL
wells	NULL
were	NULL
later	NULL
found	NULL
to	NULL
contain	NULL
proliferating	NULL
cells	NULL
,	NULL
and	NULL
these	NULL
were	NULL
expanded	NULL
.	NULL

Six	NULL
subclones	NULL
ceased	NULL
to	NULL
grow	NULL
within	NULL
several	NULL
weeks	NULL
,	NULL
so	NULL
the	NULL
cytokine-switching	NULL
experiment	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
the	NULL
remaining	NULL
nine	NULL
sub-clones	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
result	NULL
of	NULL
the	NULL
original	NULL
M-TAT/GM-CSF	NULL
cells	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
staining	NULL
cells	NULL
was	NULL
markedly	NULL
increased	NULL
when	NULL
the	NULL
cytokine	NULL
was	NULL
switched	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
for	NULL
all	NULL
nine	NULL
subclones	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
column	NULL
1	NULL
,	NULL
solid	NULL
bar	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Erythropoietin-dependent	NULL
Differentiation	NULL
in	NULL
M-TAT	NULL
Cells	NULL
3	NULL
>	NULL
Dianisidine	NULL
Positive	NULL
Cells	NULL
(	NULL
%	NULL
)	NULL
Dianisidine	NULL
Positive	NULL
Cells	NULL
(	NULL
%	NULL
)	NULL
a	NULL
o	NULL
.	NULL

GM-CSF	NULL
(	NULL
ng/m	NULL
)	NULL
O0	NULL
_	NULL
10	NULL
~	NULL
10	NULL
|	NULL
1-10	NULL
10	NULL
0	NULL
o	NULL
140	NULL
EPO	NULL
(	NULL
ng/ml	NULL
)	NULL
50	NULL
50	NULL
50	NULL
50	NULL
0	NULL
0	NULL
50	NULL
50	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Repression	NULL
by	NULL
GM-CSF	NULL
of	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
cloned	NULL
M-TAT	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
M-TAT/E-9	NULL
(	NULL
subclone	NULL
of	NULL
M-TAT/GM-CSF	NULL
)	NULL
and	NULL
M-TAT/EPO-6	NULL
(	NULL
subclone	NULL
of	NULL
M-TAT/EPO	NULL
)	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
cyto-kine-free	NULL
medium	NULL
three	NULL
times	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
50	NULL
ng/ml	NULL
of	NULL
EPO	NULL
or	NULL
0-10	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
for	NULL
7	NULL
days	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
staining	NULL
cells	NULL
in	NULL
each	NULL
culture	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
cells	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
alone	NULL
(	NULL
column	NULL
»	NULL
5	NULL
)	NULL
.	NULL

Both	NULL
M-TAT/EPO-6	NULL
cells	NULL
(	NULL
@	NULL
)	NULL
and	NULL
M-TAT/E-9	NULL
cells	NULL
(	NULL
MR	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Means	NULL
+	NULL
S.D	NULL
.	NULL

value	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
were	NULL
plotted	NULL
.	NULL

B	NULL
,	NULL
M-TAT/H-9-1	NULL
(	NULL
8	NULL
)	NULL
and	NULL
M-TAT/E-9-1	NULL
(	NULL
0	NULL
)	NULL
(	NULL
resubclones	NULL
of	NULL
M-TAT/GM-CSF	NULL
subclones	NULL
)	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
cultured	NULL
with	NULL
EPO	NULL
and/or	NULL
various	NULL
concentration	NULL
of	NULL
GM-CSF	NULL
for	NULL
4	NULL
days	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
dianisidine	NULL
to	NULL
determine	NULL
hemoglobin	NULL
content	NULL
.	NULL

Means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

We	NULL
then	NULL
resubcloned	NULL
M-TAT/H-9	NULL
and	NULL
M-TATV/E-9	NULL
(	NULL
two	NULL
of	NULL
the	NULL
nine	NULL
M-TAT/GM-CSF	NULL
subclones	NULL
)	NULL
by	NULL
seeding	NULL
10	NULL
cells/96-well	NULL
microtiter	NULL
plate	NULL
,	NULL
and	NULL
three	NULL
(	NULL
H-9-1	NULL
,	NULL
H-9-2	NULL
,	NULL
and	NULL
E-9-1	NULL
)	NULL
subclones	NULL
were	NULL
obtained	NULL
.	NULL

The	NULL
probability	NULL
that	NULL
these	NULL
subclones	NULL
would	NULL
be	NULL
of	NULL
polyclonal	NULL
origin	NULL
was	NULL
less	NULL
than	NULL
1	NULL
%	NULL
.	NULL

Cytokine-switching	NULL
experiments	NULL
using	NULL
these	NULL
subclones	NULL
confirmed	NULL
our	NULL
previous	NULL
results	NULL
that	NULL
EPO	NULL
induces	NULL
hemoglobin	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
50	NULL
M-TAT/EPO	NULL
cells	NULL
were	NULL
seeded	NULL
into	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
,	NULL
and	NULL
eight	NULL
wells	NULL
were	NULL
obtained	NULL
with	NULL
proliferating	NULL
cells	NULL
.	NULL

Of	NULL
these	NULL
M-TAT/EPO	NULL
subclones	NULL
,	NULL
four	NULL
continued	NULL
to	NULL
proliferate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
EPO	NULL
.	NULL

When	NULL
the	NULL
cytokine	NULL
was	NULL
switched	NULL
to	NULL
GM-CSF	NULL
for	NULL
one	NULL
of	NULL
the	NULL
M-TAT/EPO	NULL
subclones	NULL
(	NULL
M-TAT/EPO-6	NULL
)	NULL
,	NULL
the	NULL
culture	NULL
showed	NULL
a	NULL
substantial	NULL
decrease	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
staining	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
column	NULL
5	NULL
,	NULL
diagonally-lined	NULL
box	NULL
)	NULL
and	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
mRNAs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
observed	NULL
effect	NULL
of	NULL
adding	NULL
EPO	NULL
(	NULL
the	NULL
induction	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
)	NULL
is	NULL
due	NULL
to	NULL
clonal	NULL
expansion	NULL
of	NULL
a	NULL
heterogeneous	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
M-TAT/GM-CSF	NULL
serially	NULL
transferred	NULL
cultures	NULL
.	NULL

EPO/EPO-R	NULL
Signals	NULL
for	NULL
Erythroid	NULL
Differentiation	NULL
Are	NULL
Suppressed	NULL
by	NULL
the	NULL
Presence	NULL
of	NULL
GM-CSF-The	NULL
results	NULL
obtained	NULL
in	NULL
the	NULL
previous	NULL
section	NULL
indicate	NULL
that	NULL
,	NULL
while	NULL
signals	NULL
from	NULL
the	NULL
GM-CSF/GM-CSF-R	NULL
system	NULL
can	NULL
support	NULL
the	NULL
proliferation	NULL
of	NULL
M-TAT	NULL
cells	NULL
,	NULL
they	NULL
do	NULL
not	NULL
promote	NULL
the	NULL
differentiation	NULL
of	NULL
M-TAT	NULL
cells	NULL
along	NULL
the	NULL
erythroid	NULL
lineage	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
EPO	NULL
can	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
,	NULL
we	NULL
added	NULL
EPO	NULL
to	NULL
the	NULL
M-TAT/E-9	NULL
(	NULL
subclone	NULL
of	NULL
M-TAT/GM-CSF	NULL
)	NULL
cell	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
solid	NULL
bar	NULL
)	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
M-TAT/E	NULL
$	NULL
cells	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
switching	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
hemoglobin	NULL
synthesis	NULL
was	NULL
suppressed	NULL
by	NULL
the	NULL
simultaneous	NULL
addition	NULL
of	NULL
as	NULL
little	NULL
as	NULL
0.1	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

The	NULL
growth	NULL
of	NULL
the	NULL
original	NULL
M-TAT	NULL
cells	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
concentration	NULL
of	NULL
supplemented	NULL
GM-CSF	NULL
,	NULL
and	NULL
maximum	NULL
growth	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ng/ml	NULL
of	NULL
GM-CSF	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
a	NULL
suboptimal	NULL
concentration	NULL
of	NULL
GM-CSF	NULL
was	NULL
enough	NULL
to	NULL
cause	NULL
inhibition	NULL
of	NULL
the	NULL
hemoglobin	NULL
synthesis	NULL
in	NULL
M-TAT/E-9	NULL
cells	NULL
in	NULL
Erythropoietin-dependent	NULL
Differentiation	NULL
in	NULL
M-TAT	NULL
Cells	NULL
EPO	NULL
.	NULL

Similarly	NULL
,	NULL
GM-CSF	NULL
suppressed	NULL
EPO-induced	NULL
hemoglobin	NULL
synthesis	NULL
of	NULL
other	NULL
M-TAT/GM-CSF	NULL
subclones	NULL
,	NULL
resubcloned	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
original	NULL
M-TAT/GM-CSF	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
column	NULL
3	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Subcloned	NULL
M-TAT/EPO-6	NULL
cells	NULL
showed	NULL
a	NULL
high	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
containing	NULL
EPO	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
column	NULL
1	NULL
,	NULL
diagonally-lined	NULL
box	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
GM-CSF	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
0.01-10	NULL
ng/ml	NULL
decreased	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
dianisidine-positive	NULL
M-TAT/EPO-6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
EPO	NULL
(	NULL
50	NULL
ng/ml	NULL
(	NULL
1.67	NULL
nm	NULL
)	NULL
)	NULL
used	NULL
for	NULL
the	NULL
maintenance	NULL
of	NULL
M-TAT/EPO-6	NULL
cell	NULL
growth	NULL
easily	NULL
saturates	NULL
all	NULL
of	NULL
the	NULL
EPO-R	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
M-TAT	NULL
cells	NULL
(	NULL
as	NULL
estimated	NULL
by	NULL
receptor	NULL
binding	NULL
analysis	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
0.1	NULL
ng/ml	NULL
(	NULL
4.5	NULL
x	NULL
10	NULL
%	NULL
nm	NULL
)	NULL
of	NULL
GM-CSF	NULL
does	NULL
not	NULL
saturate	NULL
all	NULL
of	NULL
the	NULL
GM-CSF-R.*	NULL
Similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
original	NULL
M-TAT/EPO	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
cytokine-switching	NULL
experiment	NULL
and	NULL
the	NULL
receptor	NULL
binding	NULL
analysis	NULL
,	NULL
taken	NULL
together	NULL
,	NULL
imply	NULL
an	NULL
interesting	NULL
possibil-ity	NULL
.	NULL

Both	NULL
the	NULL
GM-CSF/GM-CSF-R	NULL
system	NULL
and	NULL
the	NULL
EPO/EPO-R	NULL
system	NULL
are	NULL
functional	NULL
and	NULL
signaling	NULL
in	NULL
M-TAT	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
former	NULL
overrides	NULL
or	NULL
suppresses	NULL
the	NULL
latter	NULL
.	NULL

That	NULL
is	NULL
,	NULL
the	NULL
GM-CSF	NULL
system	NULL
dictates	NULL
the	NULL
direction	NULL
of	NULL
differentiation	NULL
in	NULL
M-TAT	NULL
cells	NULL
.	NULL

Expression	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
Increases	NULL
When	NULL
the	NULL
Cytokine	NULL
Is	NULL
Changed	NULL
to	NULL
EPO-GATA	NULL
transcription	NULL
factors	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
specifically	NULL
expressed	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Functionally	NULL
important	NULL
GATA	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
of	NULL
many	NULL
erythroid-specific	NULL
genes	NULL
,	NULL
including	NULL
EPO-R	NULL
,	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
,	NULL
GATA-1	NULL
,	NULL
and	NULL
y-globin	NULL
(	NULL
9	NULL
,	NULL
29-34	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
proteins	NULL
were	NULL
both	NULL
expressed	NULL
in	NULL
M-TAT/GM-CSF	NULL
and	NULL
M-TAT/EPO	NULL
cells	NULL
by	NULL
immunohisto-chemical	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
was	NULL
examined	NULL
after	NULL
switching	NULL
the	NULL
cytokine	NULL
to	NULL
EPO	NULL
,	NULL
it	NULL
was	NULL
found	NULL
to	NULL
have	NULL
increased	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
GATA-1	NULL
mRNA	NULL
level	NULL
decreased	NULL
in	NULL
M-TAT/EPO	NULL
cells	NULL
after	NULL
switching	NULL
from	NULL
EPO	NULL
to	NULL
GM-CSF	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
GATA-1	NULL
mRNA	NULL
level	NULL
in	NULL
the	NULL
cytokine-switching	NULL
experiment	NULL
correlate	NULL
very	NULL
well	NULL
with	NULL
that	NULL
of	NULL
the	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
Sé-aminolevulinate	NULL
synthase	NULL
mRNAs	NULL
,	NULL
suggesting	NULL
that	NULL
GATA-1	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
lineage-specific	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
EPO	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
To	NULL
date	NULL
,	NULL
a	NULL
number	NULL
of	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
origin	NULL
have	NULL
been	NULL
reported	NULL
,	NULL
and	NULL
EPO-dependent	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
some	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
has	NULL
been	NULL
extensively	NULL
investigated	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
16	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
was	NULL
found	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
EPO	NULL
in	NULL
the	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
of	NULL
murine	NULL
origin	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
13	NULL
)	NULL
,	NULL
but	NULL
this	NULL
was	NULL
not	NULL
the	NULL
case	NULL
for	NULL
the	NULL
human	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
(	NULL
15	NULL
,	NULL
36	NULL
,	NULL
37	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
question	NULL
as	NULL
to	NULL
whether	NULL
EPO	NULL
can	NULL
influence	NULL
the	NULL
programming	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
,	NULL
we	NULL
cultured	NULL
M-TAT	NULL
cells	NULL
with	NULL
GM-CSF	NULL
,	NULL
EPO	NULL
,	NULL
or	NULL
SCF	NULL
for	NULL
1	NULL
year	NULL
and	NULL
prepared	NULL
three	NULL
lines	NULL
of	NULL
serially	NULL
transferred	NULL
cultures	NULL
.	NULL

Of	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
,	NULL
M-TAT/EPO	NULL
cells	NULL
were	NULL
unique	NULL
in	NULL
that	NULL
the	NULL
cells	NULL
show	NULL
markedly	NULL
increased	NULL
levels	NULL
of	NULL
mRNAs	NULL
encoding	NULL
GATA-1	NULL
,	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
,	NULL
and	NULL
y-globin	NULL
and	NULL
a	NULL
high	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
other	NULL
M-TAT	NULL
cell	NULL
cultures	NULL
.	NULL

We	NULL
then	NULL
performed	NULL
cytokine-switching	NULL
experiments	NULL
,	NULL
and	NULL
found	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
erythroid-specific	NULL
properties	NULL
was	NULL
induced	NULL
in	NULL
the	NULL
M-TAT/GM-CSF	NULL
cells	NULL
within	NULL
3	NULL
days	NULL
after	NULL
the	NULL
switch	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
EPO	NULL
signal	NULL
for	NULL
erythroid	NULL
differentiation	NULL
was	NULL
suppressed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
.	NULL

Thus	NULL
,	NULL
cytokines	NULL
actively	NULL
influence	NULL
the	NULL
programming	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
M-TAT	NULL
cells	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
three	NULL
human	NULL
EPO-dependent	NULL
cell	NULL
lines	NULL
(	NULL
TF-1	NULL
(	NULL
15	NULL
)	NULL
,	NULL
F-36	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
UT-7	NULL
(	NULL
17	NULL
,	NULL
38	NULL
)	NULL
)	NULL
have	NULL
been	NULL
reported	NULL
,	NULL
27703	NULL
A	NULL
M-TAT/EPO	NULL
M-TAT/GM-CSF	NULL
-	NULL
>	NULL
»	NULL
GM-CSF	NULL
-	NULL
»	NULL
EPO	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9101112	NULL
A	NULL
*	NULL
w	NULL
a	NULL
a	NULL
®	NULL
GATA	NULL
!	NULL

|	NULL
|	NULL
bubits	NULL
rRNA	NULL
B	NULL
a	NULL
T	NULL
T	NULL
3.0L	NULL
3	NULL
.2	NULL
|	NULL
O	NULL
§	NULL
20	NULL
_	NULL
``	NULL
G	NULL
G	NULL
CC	NULL
2	NULL
E	NULL
1.0	NULL
d	NULL
CC	NULL
00	NULL
1	NULL
i	NULL
0	NULL
20	NULL
40	NULL
Hour	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Changes	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
in	NULL
cytokine-switching	NULL
experiments	NULL
.	NULL

A	NULL
,	NULL
M-TAT/EPO	NULL
and	NULL
M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
and	NULL
cytokines	NULL
in	NULL
the	NULL
culture	NULL
media	NULL
were	NULL
changed	NULL
to	NULL
GM-CSF	NULL
(	NULL
lanes	NULL
2-6	NULL
)	NULL
and	NULL
EPO	NULL
(	NULL
lanes	NULL
8-12	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
M-TAT	NULL
cells	NULL
3	NULL
h	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
,	NULL
6	NULL
h	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
,	NULL
12	NULL
h	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
10	NULL
)	NULL
,	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
11	NULL
)	NULL
or	NULL
48	NULL
h	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
after	NULL
the	NULL
cytokine-switching	NULL
.	NULL

20	NULL
ug	NULL
of	NULL
RNA	NULL
from	NULL
these	NULL
and	NULL
RNA	NULL
harvested	NULL
from	NULL
M-TAT/EPO	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
M-TAT/GM-CSF	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
cells	NULL
was	NULL
probed	NULL
with	NULL
P-labeled	NULL
hGATA-1	NULL
cDNA	NULL
probe	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
RNA	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
28	NULL
S	NULL
ribosomal	NULL
RNA	NULL
bands	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
exposed	NULL
to	NULL
the	NULL
BAS2000	NULL
phosphor	NULL
imaging	NULL
plate	NULL
for	NULL
18	NULL
h	NULL
for	NULL
GATA-1	NULL
and	NULL
1	NULL
h	NULL
for	NULL
ribosomal	NULL
RNA	NULL
detection	NULL
.	NULL

B	NULL
,	NULL
changes	NULL
in	NULL
the	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
relative	NULL
to	NULL
that	NULL
of	NULL
the	NULL
28	NULL
S	NULL
ribosomal	NULL
RNA	NULL
in	NULL
the	NULL
cytokine-switching	NULL
experiment	NULL
from	NULL
GM-CSF	NULL
to	NULL
EPO	NULL
(	NULL
@	NULL
)	NULL
and	NULL
from	NULL
EPO	NULL
to	NULL
GM-CSF	NULL
(	NULL
O	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

and	NULL
all	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
exhibit	NULL
erythroid/megakaryocytic	NULL
properties	NULL
.	NULL

In	NULL
TF-1	NULL
cells	NULL
,	NULL
EPO	NULL
can	NULL
sustain	NULL
short-term	NULL
growth	NULL
,	NULL
but	NULL
can	NULL
not	NULL
induce	NULL
erythroid	NULL
differentiation	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Hemoglobin	NULL
is	NULL
constitutively	NULL
synthesized	NULL
in	NULL
F36E	NULL
cells	NULL
,	NULL
but	NULL
hemoglobin	NULL
synthesis	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
changing	NULL
the	NULL
cytokine	NULL
;	NULL
replacement	NULL
of	NULL
EPO	NULL
by	NULL
GM-CSF	NULL
did	NULL
not	NULL
change	NULL
the	NULL
hemoglobin	NULL
level	NULL
in	NULL
F36E	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

By	NULL
maintaining	NULL
UT-7	NULL
cells	NULL
in	NULL
media	NULL
containing	NULL
EPO	NULL
for	NULL
more	NULL
than	NULL
6	NULL
months	NULL
,	NULL
a	NULL
subline	NULL
in	NULL
which	NULL
growth	NULL
is	NULL
totally	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
EPO	NULL
was	NULL
established	NULL
(	NULL
UT-7/EPO	NULL
)	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
UT-7/EPO	NULL
cells	NULL
have	NULL
progressed	NULL
further	NULL
in	NULL
erythroid	NULL
development	NULL
than	NULL
original	NULL
UT-7	NULL
cells	NULL
,	NULL
erythroid	NULL
development	NULL
of	NULL
UT-7/EPO	NULL
cells	NULL
by	NULL
EPO	NULL
progressed	NULL
slowly	NULL
,	NULL
and	NULL
at	NULL
least	NULL
3	NULL
months	NULL
were	NULL
required	NULL
to	NULL
establish	NULL
the	NULL
UT-7/EPO	NULL
phenotype	NULL
after	NULL
the	NULL
start	NULL
of	NULL
the	NULL
cell	NULL
culture	NULL
with	NULL
EPO	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
M-TAT/GM-CSF	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
EPO	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
erythroid-specific	NULL
genes	NULL
within	NULL
48	NULL
h.	NULL
Additionally	NULL
,	NULL
UT-7/EPO	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
or	NULL
interleukin-3	NULL
(	NULL
17	NULL
)	NULL
.	NULL

As	NULL
compared	NULL
with	NULL
other	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
leukemia	NULL
origin	NULL
,	NULL
M-TAT	NULL
cells	NULL
are	NULL
unique	NULL
in	NULL
that	NULL
30-50	NULL
%	NULL
of	NULL
M-TAT/EPO	NULL
cells	NULL
27704	NULL
produce	NULL
hemoglobin	NULL
as	NULL
judged	NULL
by	NULL
dianisidine	NULL
staining	NULL
,	NULL
while	NULL
less	NULL
than	NULL
10	NULL
%	NULL
of	NULL
M-TAT/GM-CSF	NULL
cells	NULL
were	NULL
dianisidine-posi-tive	NULL
.	NULL

Replacement	NULL
of	NULL
GM-CSF	NULL
by	NULL
EPO	NULL
caused	NULL
rapid	NULL
and	NULL
significant	NULL
increases	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
dianisidine-positive	NULL
cells	NULL
,	NULL
y-globin	NULL
,	NULL
and	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
mRNA	NULL
levels	NULL
within	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
This	NULL
5-fold-plus	NULL
increase	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
solely	NULL
by	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
hemoglo-bin-producing	NULL
cells	NULL
,	NULL
because	NULL
subcloned	NULL
M-TAT/GM-CSF	NULL
cells	NULL
possess	NULL
the	NULL
same	NULL
ability	NULL
to	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
hemoglobin	NULL
in	NULL
response	NULL
to	NULL
EPO	NULL
.	NULL

This	NULL
finding	NULL
clearly	NULL
excludes	NULL
the	NULL
possibility	NULL
of	NULL
clonal	NULL
expansion	NULL
of	NULL
EPO-sensitive	NULL
M-TAT	NULL
cells	NULL
during	NULL
EPO	NULL
treatment	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
EPO	NULL
can	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
important	NULL
for	NULL
erythroid	NULL
development	NULL
in	NULL
M-TAT	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
both	NULL
GATA-1	NULL
and	NULL
GATA-2	NULL
factors	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
M-TAT	NULL
cells	NULL
by	NULL
immunohistochemistry	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
GATA-1	NULL
mRNA	NULL
increases	NULL
significantly	NULL
in	NULL
response	NULL
to	NULL
the	NULL
cytokine-switching	NULL
to	NULL
EPO	NULL
in	NULL
M-TAT/GM-CSF	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
change	NULL
in	NULL
GATA-1	NULL
mRNA	NULL
level	NULL
correlates	NULL
with	NULL
those	NULL
of	NULL
y-globin	NULL
and	NULL
erythroid-specific	NULL
8-aminolevulinate	NULL
synthase	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
increase	NULL
of	NULL
GATA-1	NULL
expression	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
a	NULL
mouse	NULL
erythroid	NULL
cell	NULL
line	NULL
,	NULL
SKT-6	NULL
,	NULL
in	NULL
response	NULL
to	NULL
EPO	NULL
(	NULL
7	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
level	NULL
of	NULL
GATA-2	NULL
mRNA	NULL
in	NULL
M-TAT	NULL
cells	NULL
did	NULL
not	NULL
change	NULL
significantly	NULL
in	NULL
response	NULL
to	NULL
EPO	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
consensus	NULL
GATA	NULL
sequences	NULL
are	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
EPO-R	NULL
(	NULL
9	NULL
,	NULL
31	NULL
)	NULL
,	NULL
y-globin	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
erythroid-specific	NULL
S-aminolevulinate	NULL
synthase	NULL
genes	NULL
(	NULL
32	NULL
)	NULL
,	NULL
the	NULL
present	NULL
results	NULL
further	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
GATA-1	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
EPO-mediated	NULL
regulation	NULL
of	NULL
the	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
(	NULL
39	NULL
)	NULL
.	NULL

At	NULL
the	NULL
outset	NULL
of	NULL
the	NULL
cytokine-switching	NULL
experiment	NULL
,	NULL
our	NULL
hypothesis	NULL
was	NULL
that	NULL
cells	NULL
cultured	NULL
in	NULL
EPO	NULL
would	NULL
be	NULL
in	NULL
a	NULL
more	NULL
advanced	NULL
state	NULL
of	NULL
differentiation	NULL
than	NULL
cells	NULL
cultured	NULL
in	NULL
GM-CSF	NULL
and	NULL
that	NULL
GM-CSF	NULL
serves	NULL
to	NULL
maintain	NULL
the	NULL
cells	NULL
rather	NULL
than	NULL
direct	NULL
them	NULL
along	NULL
a	NULL
certain	NULL
differentiation	NULL
pathway	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
EPO	NULL
signal	NULL
for	NULL
erythroid	NULL
differentiation	NULL
would	NULL
override	NULL
any	NULL
signal	NULL
from	NULL
the	NULL
GM-CSF	NULL
system	NULL
,	NULL
such	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
to	NULL
the	NULL
M-TAT/EPO	NULL
cells	NULL
would	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
erythroid	NULL
markers	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
however	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
EPO	NULL
signal	NULL
for	NULL
erythroid	NULL
development	NULL
is	NULL
clearly	NULL
suppressed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
GM-CSF	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
normal	NULL
bone	NULL
marrow	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
at	NULL
a	NULL
certain	NULL
stage	NULL
of	NULL
differentiation	NULL
lose	NULL
their	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
GM-CSF	NULL
signals	NULL
,	NULL
otherwise	NULL
,	NULL
the	NULL
erythroid	NULL
progenitor	NULL
cells	NULL
in	NULL
vivo	NULL
would	NULL
grow	NULL
continuously	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
(	NULL
which	NULL
should	NULL
be	NULL
contained	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
microen-vironment	NULL
)	NULL
and	NULL
could	NULL
not	NULL
differentiate	NULL
into	NULL
mature	NULL
erythroid	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
UT-7/EPO	NULL
cells	NULL
have	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
GM-CSF	NULL
during	NULL
the	NULL
long	NULL
term	NULL
culture	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
EPO	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Specific	NULL
activation	NULL
or	NULL
repression	NULL
of	NULL
the	NULL
cytokine	NULL
signal	NULL
trans-duction	NULL
pathways	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
during	NULL
hematopoietic	NULL
cell	NULL
differentiation	NULL
.	NULL

The	NULL
rapid	NULL
activation	NULL
and	NULL
repression	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
by	NULL
EPO	NULL
and	NULL
GM-CSF	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
M-TAT	NULL
cultures	NULL
further	NULL
support	NULL
this	NULL
hypothesis	NULL
.	NULL

Although	NULL
signals	NULL
from	NULL
the	NULL
EPO/EPO-R	NULL
system	NULL
appear	NULL
to	NULL
contribute	NULL
actively	NULL
to	NULL
the	NULL
differentiation	NULL
of	NULL
M-TAT	NULL
cells	NULL
along	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
this	NULL
pathway	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

M-TAT	NULL
cells	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
useful	NULL
model	NULL
system	NULL
to	NULL
examine	NULL
the	NULL
molecular	NULL
mechanisms	NULL
through	NULL
which	NULL
EPO	NULL
stimulates	NULL
,	NULL
and	NULL
GM-CSF	NULL
represses	NULL
,	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Erythropoietin-dependent	NULL
Differentiation	NULL
in	NULL
M-TAT	NULL
Cells	NULL
Acknowledgments-We	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Drs	NULL
.	NULL

Yasushi	NULL
Muraosa	NULL
,	NULL
Norio	NULL
Komatsu	NULL
,	NULL
Tosio	NULL
Suda	NULL
,	NULL
Katie	NULL
George	NULL
,	NULL
Linda	NULL
Ko	NULL
,	NULL
and	NULL
Ken-ichi	NULL
Arai	NULL
for	NULL
detailed	NULL
discussions	NULL
and	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Japanese	NULL
Cancer	NULL
Research	NULL
Resource	NULL
Bank	NULL
for	NULL
generous	NULL
supply	NULL
of	NULL
plasmid	NULL
JW1S1	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Damen	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Liu	NULL
,	NULL
L.	NULL
,	NULL
Cutler	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Krystal	NULL
,	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
2296-2303	NULL
2	NULL
.	NULL

Hanazono	NULL
,	NULL
Y.	NULL
,	NULL
Chiba	NULL
,	NULL
S.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
3193-3196	NULL
3	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
Tang	NULL
,	NULL
B.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
74	NULL
,	NULL
227-236	NULL
4	NULL
.	NULL

Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Komatsu	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Nakauchi	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
257	NULL
,	NULL
1138-1141	NULL
5	NULL
.	NULL

Koury	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
378-381	NULL
6	NULL
.	NULL

Enver	NULL
,	NULL
T.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Karlinsky	NULL
,	NULL
J.	NULL
,	NULL
Josephson	NULL
,	NULL
B.	NULL
,	NULL
Greenberger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
,	NULL
U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
9091-9095	NULL
.	NULL

Chiba	NULL
,	NULL
T.	NULL
,	NULL
Ikawa	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Todokoro	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19	NULL
,	NULL
3848-3848	NULL
.	NULL

Umemura	NULL
,	NULL
T.	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Stamatoyannopoulos	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
1993-1998	NULL
9	NULL
.	NULL

Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Longmore	NULL
,	NULL
G.	NULL
,	NULL
Neumann	NULL
,	NULL
D.	NULL
,	NULL
Yoshimura	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
81	NULL
,	NULL
2223-2236	NULL
10	NULL
.	NULL

Boyer	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
Bishop	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
Rogers	NULL
,	NULL
O.	NULL
C.	NULL
,	NULL
Noyes	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Frelin	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
and	NULL
Hobbs	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
2508-2512	NULL
11	NULL
.	NULL

Suda	NULL
,	NULL
J.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
Kubota	NULL
,	NULL
K.	NULL
,	NULL
Ihle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Blood	NULL
67	NULL
,	NULL
1002-1006	NULL
12	NULL
.	NULL

Wickrema	NULL
,	NULL
A.	NULL
,	NULL
Krantz	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
Winkelmann	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Bondurant	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
1940-1949	NULL
13	NULL
.	NULL

Broudy	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Nakamoto	NULL
,	NULL
B.	NULL
,	NULL
Lin	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Blood	NULL
75	NULL
,	NULL
1622-1626	NULL
14	NULL
.	NULL

Hara	NULL
,	NULL
K.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
Suda	NULL
,	NULL
J.	NULL
,	NULL
Eguchi	NULL
,	NULL
M.	NULL
,	NULL
Thie	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Nagata	NULL
,	NULL
S.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Saito	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

18	NULL
,	NULL
256-261	NULL
15	NULL
.	NULL

Kitamura	NULL
,	NULL
T.	NULL
,	NULL
Tange	NULL
,	NULL
T.	NULL
,	NULL
Terasawa	NULL
,	NULL
T.	NULL
,	NULL
Chiba	NULL
,	NULL
S.	NULL
,	NULL
Kuwaki	NULL
,	NULL
T.	NULL
,	NULL
Miyagawa	NULL
,	NULL
K.	NULL
,	NULL
Piao	NULL
,	NULL
Y.	NULL
F.	NULL
,	NULL
Miyazono	NULL
,	NULL
K.	NULL
,	NULL
Urabe	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Takaku	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

140	NULL
,	NULL
323-334	NULL
16	NULL
.	NULL

Klinken	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
,	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sct	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
8506-8510	NULL
17	NULL
.	NULL

Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Fujita	NULL
,	NULL
H.	NULL
,	NULL
Miwa	NULL
,	NULL
A.	NULL
,	NULL
Hatake	NULL
,	NULL
K.	NULL
,	NULL
Endo	NULL
,	NULL
T.	NULL
,	NULL
Okano	NULL
,	NULL
H.	NULL
,	NULL
Katsube	NULL
,	NULL
T.	NULL
,	NULL
Fukumaki	NULL
,	NULL
Y.	NULL
,	NULL
Sassa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
456-465	NULL
18	NULL
.	NULL

Guimaraes	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Berney	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Francis	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Hoffbrand	NULL
,	NULL
A.	NULL
V.	NULL
(	NULL
1984	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

12	NULL
,	NULL
535-538	NULL
19	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
20	NULL
.	NULL

Zon	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Tsai	NULL
,	NULL
S.-F.	NULL
,	NULL
Burgess	NULL
,	NULL
S.	NULL
,	NULL
Matsudaira	NULL
,	NULL
P.	NULL
,	NULL
Bruns	NULL
,	NULL
G.	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
,	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U	NULL
.	NULL

S	NULL
,	NULL
A	NULL
.	NULL

87	NULL
,	NULL
668-672	NULL
21	NULL
.	NULL

Dorfman	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Wilson	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Bruns	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
1279-1285	NULL
22	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Lim	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
Nagai	NULL
,	NULL
T.	NULL
,	NULL
Furuyama	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Regulation	NULL
of	NULL
Heme	NULL
Protein	NULL
Synthesis	NULL
,	NULL
pp	NULL
.	NULL

11-25	NULL
,	NULL
AlphaMed	NULL
Press	NULL
,	NULL
Dayton	NULL
,	NULL
OH	NULL
23	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
and	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

182	NULL
,	NULL
6-13	NULL
24	NULL
.	NULL

Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Koyota	NULL
,	NULL
H.	NULL
,	NULL
Matsui	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Hiraga	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
3317-3322	NULL
25	NULL
.	NULL

Endo	NULL
,	NULL
K.	NULL
,	NULL
Harigae	NULL
,	NULL
H.	NULL
,	NULL
Meguro	NULL
,	NULL
K.	NULL
,	NULL
Nagai	NULL
,	NULL
T.	NULL
,	NULL
Watanabe	NULL
,	NULL
N.	NULL
,	NULL
Furuyama	NULL
,	NULL
K.	NULL
,	NULL
Kameoka	NULL
,	NULL
J.	NULL
,	NULL
Okuda	NULL
,	NULL
M.	NULL
,	NULL
Hujie	NULL
,	NULL
H.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Abe	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

85	NULL
,	NULL
653-662	NULL
26	NULL
.	NULL

Martin	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Papayannopoulou	NULL
,	NULL
T.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
216	NULL
,	NULL
1233-1235	NULL
27	NULL
.	NULL

Lozzio	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Lozzio	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1975	NULL
)	NULL
Blood	NULL
45	NULL
,	NULL
321-334	NULL
28	NULL
.	NULL

Nagai	NULL
,	NULL
T.	NULL
,	NULL
Harigae	NULL
,	NULL
H.	NULL
,	NULL
Ishihara	NULL
,	NULL
H.	NULL
,	NULL
Motohashi	NULL
,	NULL
H.	NULL
,	NULL
Minegisgu	NULL
,	NULL
N.	NULL
,	NULL
Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
Hayashi	NULL
,	NULL
N.	NULL
,	NULL
Gu	NULL
,	NULL
L.	NULL
,	NULL
Andres	NULL
,	NULL
B.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
84	NULL
,	NULL
1074-1084	NULL
29	NULL
.	NULL

Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
575-581	NULL
30	NULL
.	NULL

Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
George	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Kornhauser	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Ting	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Yamamoto	NULL
,	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Semin	NULL
.	NULL

Hematol	NULL
.	NULL

28	NULL
,	NULL
158-169	NULL
31	NULL
.	NULL

Zon	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
Youssoufian	NULL
,	NULL
H.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Nati	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
10638-10641	NULL
32	NULL
.	NULL

Cox	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Bawden	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Martin	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
May	NULL
,	NULL
B.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
1891-1902	NULL
33	NULL
.	NULL

Zon	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
and	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
1812	NULL
34	NULL
.	NULL

Evans	NULL
,	NULL
T.	NULL
,	NULL
Reitman	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Felsenfeld	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
5976-5980	NULL
35	NULL
.	NULL

Kennedy	NULL
,	NULL
M.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Wagner	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Keller	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
79	NULL
,	NULL
180-190	NULL
36	NULL
.	NULL

Chiba	NULL
,	NULL
S.	NULL
,	NULL
Takaku	NULL
,	NULL
F.	NULL
,	NULL
Tange	NULL
,	NULL
T.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Misawa	NULL
,	NULL
C.	NULL
,	NULL
Sasaki	NULL
,	NULL
K.	NULL
,	NULL
Miyagawa	NULL
,	NULL
K.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
78	NULL
,	NULL
2261-2268	NULL
37	NULL
.	NULL

Hermine	NULL
,	NULL
O.	NULL
,	NULL
Mayeux	NULL
,	NULL
P.	NULL
,	NULL
Titeux	NULL
,	NULL
M.	NULL
,	NULL
Mitjavila	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Casadevall	NULL
,	NULL
N.	NULL
,	NULL
Gui-chard	NULL
,	NULL
J.	NULL
,	NULL
Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Breton-Gorius	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
3060-3069	NULL
38	NULL
.	NULL

Komatsu	NULL
,	NULL
N.	NULL
,	NULL
Nakauchi	NULL
,	NULL
H.	NULL
,	NULL
Miwa	NULL
,	NULL
A.	NULL
,	NULL
Ishihara	NULL
,	NULL
T.	NULL
,	NULL
Eguchi	NULL
,	NULL
M.	NULL
,	NULL
Moroi	NULL
,	NULL
M.	NULL
,	NULL
Okada	NULL
,	NULL
M.	NULL
,	NULL
Sato	NULL
,	NULL
Y.	NULL
,	NULL
Wada	NULL
,	NULL
H.	NULL
,	NULL
Yawata	NULL
,	NULL
Y.	NULL
,	NULL
Suda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miura	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

51	NULL
,	NULL
341-348	NULL
39	NULL
.	NULL

Chiba	NULL
,	NULL
T.	NULL
,	NULL
Nagata	NULL
,	NULL
Y.	NULL
,	NULL
Kishi	NULL
,	NULL
A.	NULL
,	NULL
Sakamaki	NULL
,	NULL
K.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Yamamoto	NULL
,	NULL
M.	NULL
,	NULL
Engel	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Todokoro	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
11593-11597	NULL
go	NULL
=2	NULL

